Pluribus Labs’s Salesforce CRM Stock Holding History

Pluribus Labs’s Portfolio CRM Stock Details CRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-846	Closed	-$215K	–	95
2021 Q4	$215K	Buy	+846	New	+$238K	0.23%	201

Other funds holding CRM

WestEnd Advisors Charlotte, North Carolina $4.14B AUM 15.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Pluribus Labs's CRM Position: Q1 2022 in Review

Pluribus Labs sold out of Salesforce (CRM) in Q1 2022, closing a stake of 846 shares — an estimated $215K sold.

Pluribus Labs first reported a position in CRM in Q4 2021 and held it in 1 quarter. The position peaked at $215K in Q4 2021. 2,277 funds tracked by Wall St. Rank hold CRM as of Q1 2022.

Pluribus Labs reported no remaining Salesforce position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 846 Salesforce shares in Q1 2022, an estimated $215K.
Pluribus Labs first reported a position in Salesforce in Q4 2021 and held it in 1 quarter.
Pluribus Labs's Salesforce position peaked at $215K in Q4 2021.
2,277 funds tracked by Wall St. Rank held Salesforce as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.